Logo
Your free order overview
You currently have not items to display
Logo
Your contact details

This is a required field

Logo
Thank you!

Thank you for choosing Janssen Medical Cloud for ordering your materials.

/
Uptravi improves hemodynamic parameters

Uptravi improves hemodynamic parameters

REFERENCE

1. Simonneau G, Torbicki A, Hoeper MM, et al. Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. Eur Respir J. 2012; 40 (4): 874-880.

CP-266805

Logo
This site is published by ©Johnson & Johnson Innovative Medicine NV which is solely responsible for its content. It is intended for European, Middle Eastern and African Healthcare professionals.
Johnson & Johnson Pharmaceutica NV
Legal NoticeCookie PolicyPrivacy Policy
Cookie Settings